Springer.com | SpringerLink.com
Register | Log in
Home | About | For Libraries | Contact Us | Help
Show advanced options
 

Expression of brlA(p/l)::lacZ, abaA(p/l)::lacZ, and medA(p/l)::lacZ in the wild-type strain and ΔchsA ΔchsC double mutant. a Messenger RNA levels of brlA,abaA,medA, and lacZ. Total RNA was extracted from strains cultured for 0 or 24 h on solid MMG after being transferred from liquid MMG. Strains used are ///pJA22-1 (wild type containing brlA(p/l)::lacZ), ΔAC/pJA22-2 (ΔchsA ΔchsC mutant containing brlA(p/l)::lacZ), ///pABAL-8 (wild type containing abaA (p/l)::lacZ), ΔAC/pABAL-6 (ΔchsA ΔchsC mutant containing abaA (p/l)::lacZ), ///pML-2 (wild type containing medA(p/l)::lacZ), and ΔAC/pML-3 (ΔchsA ΔchsC mutant containing medA(p/l)::lacZ). Ribosomal RNA (rRNA) stained with ethidium bromide is shown as a loading control. b–e In-situ staining. ///pJA22-1 (bupper panel), ΔAC/pJA22-2 (blower panel), ///pABAL-8 (cupper panel), ΔAC/pABAL-6 (clower panels), ///pML-2 (dupper panel), ΔAC/pML-3 (dlower panel), ///-10 (wild type, eupper panel), and ΔAC/A-4 (ΔchsA ΔchsC mutant, elower panel) were grown on solid MMG for 24 h and subjected to in-situ staining as described in the text

Caption

Fig 3 

Expression of brlA(p/l)::lacZ, abaA(p/l)::lacZ, and medA(p/l)::lacZ in the wild-type strain and ΔchsA ΔchsC double mutant. a Messenger RNA levels of brlA,abaA,medA, and lacZ. Total RNA was extracted from strains cultured for 0 or 24 h on solid MMG after being transferred from liquid MMG. Strains used are ///pJA22-1 (wild type containing brlA(p/l)::lacZ), ΔAC/pJA22-2 (ΔchsA ΔchsC mutant containing brlA(p/l)::lacZ), ///pABAL-8 (wild type containing abaA (p/l)::lacZ), ΔAC/pABAL-6 (ΔchsA ΔchsC mutant containing abaA (p/l)::lacZ), ///pML-2 (wild type containing medA(p/l)::lacZ), and ΔAC/pML-3 (ΔchsA ΔchsC mutant containing medA(p/l)::lacZ). Ribosomal RNA (rRNA) stained with ethidium bromide is shown as a loading control. b–e In-situ staining. ///pJA22-1 (bupper panel), ΔAC/pJA22-2 (blower panel), ///pABAL-8 (cupper panel), ΔAC/pABAL-6 (clower panels), ///pML-2 (dupper panel), ΔAC/pML-3 (dlower panel), ///-10 (wild type, eupper panel), and ΔAC/A-4 (ΔchsA ΔchsC mutant, elower panel) were grown on solid MMG for 24 h and subjected to in-situ staining as described in the text

Extracts from the Article What's this?

Northern analysis confirmed the similarity of expressions of these fusion genes to those of brlA , abaA , and medA (Fig.  3 a).

In in-situ staining, expressions of brlA (p/l): lacZ and abaA (p/l):: lacZ were detected in morphologically aberrant sterigmata and conidiophore vesicles of the ΔAC mutants (Fig.  3 b, c).

Regarding the ΔAC mutants with abaA (p/l):: lacZ , we readily found poorly stained conidiophores that had developed long chains of aberrant sterigmata in the ΔAC mutant (Fig.  3 c, left).

Expression of medA (p/l):: lacZ was observed in both hyphae and conidiophores in either the wild-type or ΔAC mutant strains (Fig.  3 d).

The results of in-situ staining (Fig.  3 ) suggest that induction of abaA expression does not occur during reiteration of abnormal sterigmata, while brlA and medA are expressed.

Northern analysis (Fig.  2 ) and in-situ staining (Fig.  3 ) revealed that medA expression in the ΔAC mutants was not disturbed.

Viewing this image requires a subscription. If you are a subscriber, please log in.

  • Individual Subscription
  • Recommend to Librarian
  • Get a Free Trial or Quote
  • Free Images

Other Images from this Article

x

License

This image is copyrighted by Springer-Verlag.

The image is being made available for non-commercial purposes for subscribers to SpringerImages. For more information on what you are allowed to do with this image, please see our copyright policy.

If you would like to obtain permissions for the re-use or re-print of this image, please click here.

Report a copyright concern regarding this image.

Log in or register to save your
favorite images and download
them as high-quality
PowerPoint or PDF files.

Log in or register to save your search criteria.



© Springer 2010. Produced by Current Medicine Group Ltd, a part of Springer Science+Business Media

Home | About | Contact Us | Privacy Policy | Terms of Use | RSS | Help